Global Cold, Cough, and Sore Throat Remedies Market is Expected to be Worth US$ 36,325.0 Mn in 2019 and is Predicted to Grow to US$ 46,869.6 Mn by The End of 2027

Cold, Cough, and Sore Throat Remedies

The common cold spreads from person to person via a variety of means, including cough droplets, sneezes, and mucus in the hand. Seasonal variables, direct contact with an infected individual, smoking and exposure to cigarette smoke, a weakened immune system, and numerous chronic illnesses such as diabetes, autoimmune diseases, and asthma are all common causes of colds.

Drivers of the Global Cold, Cough, and Sore Throat Remedies Market

Over the projected period, the global Cold, Cough, and Sore Throat Remedies Market are expected to rise due to an increase in patient self-medication and the availability of over-the-counter (OTC) pharmaceuticals. For example, according to the study 'Self-medication with over-the-counter drugs, the prevalence of the risky practice, and its associated factors in pharmacy outlets of Asmara, Eritrea,' published in the journal BMC Public Health in February 2019, 93.7 percent of survey participants used OTC drugs for self-medication. Analgesics were the most often preferred OTC medicine category, followed by antipyretics and cough and cold preparations.

Restriction in the Global Cold, Cough, and Sore Throat Remedies Market. However, over-the-counter sore throat medications may contribute to antibiotic resistance, which is predicted to limit their use, stifling market growth. For example, according to a study presented in April 2019 at the 29th European Congress of Clinical Microbiology & Infectious Diseases, OTC throat products may contribute to antibiotic resistance.

Opportunities in the global Cold, Cough, and Sore Throat Remedies Market. Moving a product from prescription to over-the-counter (OTC) creates an appealing opportunity for manufacturers. For example, according to the Consumer Healthcare Products Association, OTC drug sales in the United States reached US$ 35.2 billion in 2018, up from US$ 34.6 billion in 2017. The emergence of novel coronaviruses is also predicted to assist market expansion. For example, in January 2020, China reported 2,700 cases of a novel coronavirus with symptoms similar to a normal cold, including a runny nose, headache, fever, cough, sore throat, and overall malaise.